Bojarska-Junak A - Search Results

1

Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia.

Hus I, Roliński J, Tabarkiewicz J, Wojas K, Bojarska-Junak A, Greiner J, Giannopoulos K, Dmoszyńska A, Schmitt M. Hus I, et al. Leukemia. 2005 Sep;19(9):1621-7. doi: 10.1038/sj.leu.2403860. Leukemia. 2005. PMID: 15990861 Clinical Trial.

2

[CD43 in B-cell chronic lymphocytic leukemia].

Roliński J, Rupniewska ZM, Dmoszyńska A, Wasik-Szczepanek E, Bojarska-Junak A. Roliński J, et al. Pol Arch Med Wewn. 1999 Sep;102(3):753-62. Pol Arch Med Wewn. 1999. PMID: 10949882 Review. Polish.

3

[Universal CD43 molecule].

Rupniewska ZM, Roliński J, Bojarska-Junak A. Rupniewska ZM, et al. Postepy Hig Med Dosw. 2000;54(5):619-38. Postepy Hig Med Dosw. 2000. PMID: 11146890 Review. Polish.

4

Influence of thalidomide on Bcl2 expression and proangiogenic cytokine levels in short-term culture of peripheral blood and bone marrow mononuclear cells of multiple myeloma patients.

Dmoszyńska A, Roliński J, Bojarska-Junak A, Mańko J, Jawniak D, Walter-Croneck A, Soroka-Wojtaszko M, Hus M. Dmoszyńska A, et al. Pol J Pharmacol. 2001 Nov-Dec;53(6):709-13. Pol J Pharmacol. 2001. PMID: 11985351 Free article.

5

Production of proangiogenic cytokines during thalidomide treatment of multiple myeloma.

Dmoszyńska A, Bojarska-Junak A, Domański D, Roliński J, Hus M, Soroka-Wojtaszko M. Dmoszyńska A, et al. Leuk Lymphoma. 2002 Feb;43(2):401-6. doi: 10.1080/10428190290006224. Leuk Lymphoma. 2002. PMID: 11999576

6

Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.

Bojarska-Junak A, Rolinski J, Wasik-Szczepaneko E, Kaluzny Z, Dmoszynska A. Bojarska-Junak A, et al. Haematologica. 2002 May;87(5):490-9. Haematologica. 2002. PMID: 12010662

7

Evaluation of myeloid and lymphoid dendritic cells in peritoneal fluid in women with non-malignant ovarian tumors.

Wertel I, Kotarski J, Roliński J, Bojarska-Junak A, Gogacz M. Wertel I, et al. Am J Reprod Immunol. 2003 Sep;50(3):238-42. doi: 10.1034/j.1600-0897.2003.00081.x. Am J Reprod Immunol. 2003. PMID: 14629029

8

The influence of thalidomide therapy on cytokine secretion, immunophenotype, BCL-2 expression and microvessel density in patients with resistant or relapsed multiple myeloma.

Dmoszynska A, Podhorecka M, Manko J, Bojarska-Junak A, Rolinski J, Skomra D. Dmoszynska A, et al. Neoplasma. 2005;52(2):175-81. Neoplasma. 2005. PMID: 15800717 Clinical Trial.

9

Modification of immunocytochemical ZAP-70 assay for potential clinical application in B-cell chronic lymphocytic leukemia.

Bojarska-Junak A, Roliński J, Kawiak J. Bojarska-Junak A, et al. Folia Histochem Cytobiol. 2005;43(1):19-23. Folia Histochem Cytobiol. 2005. PMID: 15871558

10

Antioxidative and anti-inflammatory effects of repaglinide in plasma of diabetic animals.

Gumieniczek A, Hopkała H, Roliński J, Bojarska-Junak A. Gumieniczek A, et al. Pharmacol Res. 2005 Aug;52(2):162-6. doi: 10.1016/j.phrs.2005.02.019. Pharmacol Res. 2005. PMID: 15967382

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters